Enanta Pharmaceuticals Inc. sell StockNews.com
Start price
06.04.24
/
50%
€15.20
Target price
06.04.25
-
Performance (%)
-72.89%
End price
07.04.25
€4.12
Summary
This prediction ended on 07.04.25 with a price of €4.12. StockNews_com correctly predicted massive losses of -72.89% for Enanta Pharmaceuticals Inc.. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Enanta Pharmaceuticals Inc. | 0.901% | 0.901% | 73.643% |
| iShares Core DAX® | 2.591% | 2.691% | 6.411% |
| iShares Nasdaq 100 | -0.915% | -7.368% | 20.651% |
| iShares Nikkei 225® | 0.145% | -10.196% | 46.169% |
| iShares S&P 500 | -0.367% | -0.833% | 18.019% |
Comments by StockNews_com for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for ENTA provided by MarketBeat
In the thread Trading Enanta Pharmaceuticals Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.70
30.09.23
30.09.23
-
30.09.24
30.09.24
-10.75%
01.10.24
01.10.24
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€13.00
02.09.23
02.09.23
-
02.09.24
02.09.24
-14.62%
03.09.24
03.09.24

